Velcade (Bortezomib) Consolidation After Transplant
Status:
Completed
Trial end date:
2018-01-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if bortezomib when added to consolidation treatment
with thalidomide and prednisolone leads to an improved response in patients with multiple
myeloma who have undergone autologous stem cell transplant and initial treatment with
bortezomib, cyclophosphamide, and dexamethasone.